VKH
CORV

Virtu KCG Holdings’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Virtu KCG Holdings’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,677
Closed -$47K – 3735
2017
Q1 		$47K Buy
+15,677
New +$46.2K ﹤0.01% 2855
2016
Q2 		– Sell
-10,001
Closed -$41K – 3491
2016
Q1 		$41K Buy
+10,001
New +$53.5K ﹤0.01% 2503
2014
Q1 		– Sell
-12,740
Closed -$79K – 4287
2013
Q4 		$79K Sell
12,740
-1,408
-10% -$7.38K ﹤0.01% 3504
2013
Q3 		$50K Buy
+14,148
New +$32.2K ﹤0.01% 3513

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return

Virtu KCG Holdings's CORV Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2017, closing a stake of 15,677 shares — an estimated $47K sold.

Virtu KCG Holdings first reported a position in CORV in Q3 2013 and held it in 4 quarters. The position peaked at $79K in Q4 2013. 27 funds tracked by Wall St. Rank hold CORV as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 15,677 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2017, an estimated $47K.
  • Virtu KCG Holdings first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2013 and held it in 4 quarters.
  • Virtu KCG Holdings's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $79K in Q4 2013.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.